Related references
Note: Only part of the references are listed.Monitoring for Lack of Benefit: A Critical Component of a Randomized Clinical Trial
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
Sumithra J. Mandrekar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Use of Genomics in Clinical Trial Design
Richard Simon
CLINICAL CANCER RESEARCH (2008)
Cooperative Group Research Efforts in Lung Cancer 2008: Focus on Advanced-Stage Non-Small-Cell Lung Cancer
Heather Wakelee et al.
CLINICAL LUNG CANCER (2008)
The Process to Discover and Develop Biomarkers for Cancer: A Work in Progress
David F. Ransohoff
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Edward S. Kim et al.
LANCET (2008)
Pharmacogenetics in lung cancer for the lay doctor
Rafael Rosell et al.
TARGETED ONCOLOGY (2008)
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer
Ian A. Cree et al.
ANTI-CANCER DRUGS (2007)
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression:: A phase III trial in non-small-cell lung cancer
Manuel Cobo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
TAILORx: Trial assigning individualized options for treatment (Rx)
Joseph A. Sparano
CLINICAL BREAST CANCER (2006)
被撤回的出版物: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007)
Anil Potti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clinical trials design and treatment tailoring: General principles applied to breast cancer research
P. Therasse et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Clinical trial designs for prospective validation of biomarkers
SJ Mandrekar et al.
AMERICAN JOURNAL OF PHARMACOGENOMICS (2005)
Clinical trial design for microarray predictive marker discovery and assessment
L Pusztai et al.
ANNALS OF ONCOLOGY (2004)
Evaluating the efficiency of targeted designs for randomized clinical trials
R Simon et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
